Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 4/20 | 0.51 |
| ▸ | FLT3 | P36888 | 6/20 | 0.47 |
| ▸ | KIT | P10721 | 6/20 | 0.47 |
| ▸ | ABL1 | P00519 | 2/20 | 0.46 |
| ▸ | BCR | P11274 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL741392 | 0.93 | FLT3 (0.51) | AURKAFLT3KITABL1BCR | |
| SCHEMBL741957 | 0.92 | AURKA (0.58) | AURKAFLT3KITABL1BCR | |
| SCHEMBL741482 | 0.91 | AURKA (0.49) | AURKAFLT3KITABL1BCR | |
| SCHEMBL742468 | 0.88 | AURKA (0.50) | AURKAFLT3KITABL1BCR | |
| SCHEMBL743305 | 0.88 | KIT (0.49) | AURKAFLT3KITABL1BCR | |
| SCHEMBL740517 | 0.88 | AURKA (0.65) | AURKAFLT3KITABL1BCR | |
| SCHEMBL741121 | 0.85 | KIT (0.50) | AURKAFLT3KITABL1BCR | |
| SCHEMBL738756 | 0.83 | AURKA (0.55) | AURKAFLT3KITABL1BCR | |
| SCHEMBL740798 | 0.83 | ABL1 (0.59) | AURKAFLT3KITABL1BCR | |
| SCHEMBL742323 | 0.83 | ABL1 (0.61) | AURKAFLT3KITABL1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138217-B2 | Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2012-03-20 | — | — | US | disclosed |